Ruptured hepatocellular carcinoma following chemoembolization: A western experience

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 1, 2007, Pages 49-51

  Battula, Narendra ^a   Srinivasan, Parthi ^a   Madanur, Mansoor ^a   Chava, Srinivas Prabhu ^a   Priest, Oliver ^a   Rela, Mohamed ^a   Heaton, Nigel ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Carcinoma, hepatocellular; Chemoembolization; Life threatening complications; Rupture; Ruptured hepatocellular tumor

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; FEMALE; HUMAN; INCIDENCE; INOPERABLE CANCER; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER CELL CARCINOMA RUPTURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RUPTURE; SEX DIFFERENCE; TUMOR GROWTH; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RUPTURE, SPONTANEOUS;

EID: 33846967471     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
2. El Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002;35(Suppl 2):S72-78.
3. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35: 519-524.
4. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival: Hepatology 2003;37:429-442.
5. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chernoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
6. Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, et al. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate; Hepatogastroenterology 2001;48:1409-1415.
7. Berger DH, Carrasco CH, Hohn DC, Curley SA. Hepatic artery chernoembolization or embolization for primary and metastatic liver tumours: post-treatment management and complications. J Surg Oncol 1995;60:116-121.
8. Chearanai O, Plengvanit U, Asavanich C, Damrongsak D, Sindhvananda K, Boonyapisit S. Spontaneous rupture of primary hepatoma: report of 63 cases with particular reference to the pathogenesis and rationale treatment by hepatic artery ligation. Cancer 1983;51:1532-1536.
9. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990;211:277-287.
10. Zhu LX, Meng XL, Fan ST. Elasticity of small artery in patient with spontaneous rupture of hepatocellular carcinoma. Hepatol Res 2004;29:13-17.
11. Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, et al. Complications associated with transcatheter arterial embolization for hepatic tumours. Radiographics 1998;18:605-619.
12. Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chernoembolization. Radiology 1996; 198:33-40.
13. Liu CL, Ngan H, Lo CM, Fan ST. Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization. Br J Surg 1998;85:512-514.